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Since the early nineties, many Portuguese beekeepers have intensively used 
various ways of applying fluvalinate into their honey bee colonies. This behaviour 
has imposed a strong selection pressure towards fluvalinate-tolerant Varroa 
populations, some of which were recently ident ified in a nationwide study (via 
fie ld and laboratory testing). Being able to locate such populations opened up the 
possibility to challenge them against rightly applied Apistan field treatments, as 
well as to estimate how promptly those populations move back to normal levels 
of susceptibility to this acaricide. 
Fluvalinate-tolerant Varroa populations were brought into practically Varroa-free 
experimental colonies in worker brood samples. During the following 4 months, 
those colonies were treated twice (with Apistan and Apivar) and periodically 
monitored for apparent Varroa infestation levels (in worker brood and adult bees) , 
as well as daily rates of Varroa mortality. At the end of the experiment, one thymol 
(Apiguard) treatment was applied to all experimental colonies, before sampling 
bees and brood, to control for Varroa that could eventually have managed to 
survive previous acaricide applications. 
The results we obtained clearly suggest that Varroa populations that were 
previously pin-pointed as being highly tolerant to fluvalinate, quickly go back to a 
position of high susceptibility to an appropriately applied Apistan field treatment 
(overall mean efficacy of 86 %) if kept apart, for a few months only, from close 
contact with fluvalinate 
